Source: Annual Congress 2007 - Smoking cessation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Bolin, H. Gilljam, A. C. Mörk, B. Lindgren (Lund, Stockholm, Sollentuna, Sweden). Costs and benefits accruing from smoking cessation with varenicline. Eur Respir J 2007; 30: Suppl. 51, 3028

Member's Comments

No comment yet.

Related content which might interest you: Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards Year: 2015 Cost-effectiveness of varenicline for smoking cessation in the Netherlands Source: Eur Respir J 2007; 30: Suppl. 51, 247s Year: 2007 The impact and costs of reimbursed smoking cessation using varenicline in Denmark Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine Year: 2010 Causes of quitting treatment with varenicline in a smoking cessation clinic Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Effectiveness of varenicline treatment in a smoking cessation clinic Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Effectiveness and cost-effectiveness of smoking cessation interventions Source: International Congress 2015 – New advances in smoking cessation interventions Year: 2015 The cost-effectiveness of smoking cessation interventions. Accounting for medical costs in longer life expectancies Source: Annual Congress 2006 - How to treat tobacco smokers Year: 2006 Annual budgetary impact of varenicline as part of a smoking cessation strategy in Greece Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards Year: 2015 The costs of smoking and the economics of smoking cessation Source: Eur Respir Mon; 2008: 42: 23–34 Year: 2008 Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion Source: Eur Respir J 2004; 24: Suppl. 48, 463s Year: 2004 Improvement of quit smoking rate by combining varenicline and nicotine replacement therapy Source: Annual Congress 2009 - Smoking cessation Year: 2009 Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD Source: Annual Congress 2010 - Smoking related disorders and smoking cessation Year: 2010 Cost-effectiveness of 5 smoking cessation interventions Source: Eur Respir J 2004; 24: Suppl. 48, 463s Year: 2004 Factors associated with abstinence and effectiveness of a smoking cessation program Source: Eur Respir J 2006; 28: Suppl. 50, 390s Year: 2006 Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008 Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products Year: 2016 Is NRT in combination with other drugs more effective than NRT alone in smoking cessation? Source: ISSN=ISSN 1810-6838, ISBN=, page=246 Year: 2005 Quitting smoking: the benefits Source: Breathe, 13 (3) 263; 10.1183/20734735.ELF133 Year: 2017